Sanofi SA (SNY)
47.98
+0.20
(+0.42%)
USD |
NASDAQ |
Nov 21, 16:00
47.98
0.00 (0.00%)
After-Hours: 20:00
Sanofi Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2024 | 0.2991 |
| March 31, 2024 | |
| December 31, 2023 | 0.2214 |
| September 30, 2023 | |
| June 30, 2023 | 0.2607 |
| March 31, 2023 | |
| December 31, 2022 | 0.2545 |
| September 30, 2022 | |
| June 30, 2022 | 0.2679 |
| March 31, 2022 | |
| December 31, 2021 | 0.2957 |
| September 30, 2021 | |
| June 30, 2021 | 0.3188 |
| March 31, 2021 | |
| June 30, 2020 | 0.3749 |
| March 31, 2020 | |
| December 31, 2019 | 0.418 |
| September 30, 2019 | |
| June 30, 2019 | 0.4525 |
| March 31, 2019 | |
| December 31, 2018 | 0.4185 |
| September 30, 2018 | |
| June 30, 2018 | 0.515 |
| March 31, 2018 | |
| December 31, 2017 | 0.2687 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 0.3228 |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.2852 |
| September 30, 2015 | |
| June 30, 2015 | 0.2602 |
| March 31, 2015 | |
| December 31, 2014 | 0.264 |
| September 30, 2014 | |
| June 30, 2014 | 0.2865 |
| March 31, 2014 | |
| December 31, 2013 | 0.2564 |
| September 30, 2013 | |
| June 30, 2013 | 0.2615 |
| March 31, 2013 | |
| December 31, 2012 | 0.2534 |
| September 30, 2012 | |
| June 30, 2012 | 0.2879 |
| March 31, 2012 | |
| December 31, 2011 | 0.2747 |
| September 30, 2011 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.2214
Minimum
Dec 2023
0.418
Maximum
Dec 2019
0.3012
Average
0.2957
Median
Dec 2021
Debt to Equity Ratio Benchmarks
| AstraZeneca PLC | 0.7402 |
| GSK PLC | 1.146 |
| Eli Lilly and Co | 2.185 |
| Novavax Inc | -0.3215 |
| Regeneron Pharmaceuticals Inc | 0.0677 |
Debt to Equity Ratio Related Metrics
| Net Debt Paydown Yield | 2.85% |